Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Nov-Dec;34(7):706-13.
doi: 10.3747/pdi.2012.00004. Epub 2014 Mar 1.

Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients

Jie Dong  1 , Yan-Jun Li  1 , Zhi-Kai Yang  1 , Rong Xu  1
Affiliations
Comparative Study

Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients

Jie Dong et al. Perit Dial Int. 2014 Nov-Dec.

Abstract

Objective: We explored associations between markers of endothelial dysfunction and outcome events, and whether those associations were independent of residual renal function (RRF) in patients on peritoneal dialysis.

Methods: The study enrolled 261 incident patients and 68 healthy control subjects who were followed till death, censoring, or study end. Demographics, biochemistry, markers of inflammation (C-reactive protein) and endothelial dysfunction [soluble intercellular adhesion molecule 1 (sICAM), soluble vascular adhesion molecule 1 (sVCAM), and von Willebrand factor (vWf)] were examined at baseline. Outcome events included all-cause death and fatal and nonfatal cardiovascular (CV) events.

Results: Mean levels of vWf, sICAM, and sVCAM were significantly higher in patients than in healthy control subjects. Levels of sICAM and sVCAM, but not vWf, were significantly correlated with RRF. Levels of sICAM and vWf both predicted all-cause mortality and fatal and nonfatal CV events after adjustment for recognizable CV risk factors. The association between sICAM and outcome events disappeared after further adjustment for RRF. However, RRF did not change the predictive role of vWf for outcome events. Compared with the lowest vWf quartile (6.6% - 73.9%), the highest vWf quartile (240.9% - 1161%) predicted the highest risk for fatal and nonfatal CV events (adjusted hazard ratio: 2.05; 95% confidence interval: 1.15 to 3.64; p = 0.014). We observed no associations between sVCAM and RRF, or sVCAM and any outcome event.

Conclusions: The prognostic value of vWf, but not sICAM, is independent of RRF in predicting mortality and CV events.

Keywords: Cardiovascular mortality; sICAM; sVCAM; soluble intercellular adhesion molecule 1; soluble vascular adhesion molecule 1; vWf; von Willebrand factor.

PubMed Disclaimer

Figures

Figure 1 —
Figure 1 —
Adjusted hazard ratios (HRs) for fatal and nonfatal cardiovascular events by quartile of von Willebrand factor (vWf), determined using Cox proportional hazards regression models. Adjusted variables were age, sex, body mass index, diabetes, background cardiovascular disease, baseline mean arterial pressure, hemoglobin, serum phosphate, residual renal function, and low-density lipoprotein cholesterol. Compared with the first quartile of vWf, the fourth quartile had an adjusted HR for fatal and nonfatal cardiovascular events of 2.05 (95% confidence interval: 1.15 to 3.64; p = 0.014).
See this image and copyright information in PMC

References

    1. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050–65. - PubMed
    1. Elsayed EF, Tighiouart H, Griffith J, Kurth T, Levey AS, Salem D, et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med 2007; 167:1130–6. - PubMed
    1. Yilmaz MI, Sonmez A, Qureshi AR, Saglam M, Stenvinkel P, Yaman H, et al. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol 2011; 6:1617–25. - PubMed
    1. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358:2113–17. - PubMed
    1. Suliman ME, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P. Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. Nephrol Dial Transplant 2006; 21:1603–10. - PubMed

Publication types

MeSH terms